An analysis of several breast cancer databases revealed that chemerin expression was significantly downregulated in malignant breast tissue compared to adjacent healthy tissue and that low chemerin expression was associated with poorer survival outcomes [110]. The gene discussed is RARRES2; the disease is breast carcinoma.